Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03737383 · ClinicalTrials.gov registry record · NA

Treating Violence-related PTSD and Substance Risk in Low-income, Urban Adolescents

A NA study of Posttraumatic Stress Disorder and Substance Use Disorders, sponsored by State University of New York at Buffalo.

Completed
Registry status
NA
Development phase
21
Enrollment target
1
Study location

NCT03737383 is a NA study of Posttraumatic Stress Disorder and Substance Use Disorders that has completed, run by State University of New York at Buffalo. The registered enrollment target is 21 participants, below the 112-participant average among 117 other Posttraumatic Stress Disorder trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03737383, a NA study of Posttraumatic Stress Disorder and Substance Use Disorders, has completed, sponsored by State University of New York at Buffalo.

COMPLETED
Registry status
NA
Development phase
21 participants
Enrollment target
1
Study location

Study Summary

This project will provide initial feasibility and efficacy data for the implementation of Narrative Exposure Therapy (NET) to urban, at-risk youth. Posttraumatic stress and substance use outcomes, as well as participant responses to the intervention, will be examined.

Interventions

  • BEHAVIORAL Narrative Exposure Therapy

Study Locations (1)

New York

  • University at Buffalo Department of Psychology - Buffalo

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2017-12-01
Est. Completion 2021-08-31
Phase NA

What the Registry Record Tells You About NCT03737383

The ClinicalTrials.gov registry entry for NCT03737383 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 112-participant average among 117 other Posttraumatic Stress Disorder trials with a reported enrollment target (81% lower). The listed sponsor is State University of New York at Buffalo, which has 243 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Posttraumatic Stress Disorder appearing as the primary indexed condition, and to 1 intervention - of which Narrative Exposure Therapy is the first listed.

NCT03737383 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT03737383 about?

NCT03737383 is a clinical study titled "Treating Violence-related PTSD and Substance Risk in Low-income, Urban Adolescents". This project will provide initial feasibility and efficacy data for the implementation of Narrative Exposure Therapy (NET) to urban, at-risk youth. Posttraumatic stress and substance use outcomes, as well as participant responses to the intervention, will be examined.

What is the current status of trial NCT03737383?

This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2017-12-01. Estimated completion is 2021-08-31.

What conditions does trial NCT03737383 study?

This clinical trial studies the following conditions: Posttraumatic Stress Disorder, Substance Use Disorders.

What interventions are being tested in trial NCT03737383?

The interventions under investigation include: Narrative Exposure Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT03737383?

This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03737383 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Posttraumatic Stress Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.